Congrats to ⁦MD Anderson Cancer Center⁩ brachytherapy team for completing the first prostate case in our new suite with both MRI and CT capabilities. ⁦Steven J. Frank, MD⁩ ⁩ #radonc #endcancer

Congrats to my superstar co-resident Alexander Sherry!!!

Truly honored to cap off the AACR ASCO Clinical Trial Workshop with the award for Most Innovative Protocol! Huge thank you to workshop faculty, many new friends, and leadership MD Anderson Cancer Center for supporting this incredible week!

Our faculty are so amazing and special— please meet and greet them tomorrow!

Super proud of superstar co-resident Benjamin Schrank, MD, PhD!!! #c/o2025

Congrats to our Mary Fletcher Memorial Heart ❤️ of Caring Award recipients for this year! @RadiantRehema Enoch Chang Michael Rooney #RadOnc #residents MD Anderson Cancer Center Chelsea C Pinnix MD PhD Prajnan Das, MD, MS, MPH Emma B. Holliday MD Albert Koong, MD PhD

Fascinating work by Justin Jagodinsky and colleagues showing how #radiation ☢️ dose heterogeneity drives response to #immunotherapy in Science Translational Medicine! Could this get us one step closer to achieving #abscopal effects in clinic? 🤔

One of my favorite parts of ASTRO is meeting all of the med students! 📢#medstudent(s) at #ASTRO2024 come meet my amazing MDACC #radonc ☢️ family! 📆When? Sunday 9/29, 3-4 PM 📍Where? MDACC Booth #741 🧑‍🧑‍🧒‍🧒Why? Get to know future co-residents & our #MedEd leaders!

FASTRACK II 100% LC and 100% CSS An excellent option for many patients with RCC

Congrats to my outstanding co-resident Patrick P. Carriere, MD, PhD for an excellent talk on clinically important #PROs for patients with prostate cancer 🔥

If you want to get started with benign #RadOnc, the best first thing to do in my opinion is educate your colleagues. LDRT is a standard of care therapy, it is covered by insurance, and there are decades of evidence to support its efficacy.

#RadOnc Heme High-Yield Oral Boards: 2025 Update! Some key slides highlighted below. Feedback or commentary is welcome. Good luck everyone! docs.google.com/presentation/d…

Metastasis-directed radiation therapy can help patients with oligometastatic clear cell renal cell carcinoma avoid systemic therapies without compromising outcomes, findings shared by our Dr. Chad Tang at #AACR25 show. More: brnw.ch/21wSeae AACR Chad Tang, MD #EndCancer

Had such a fun 🤩 night celebrating our amazing MD Anderson Cancer Center #RadOnc #residents #fellow ☢️ #Classof2025 grads! 🌟 Albert Koong, MD PhD Prajnan Das, MD, MS, MPH Emma B. Holliday MD Chelsea C Pinnix MD PhD Vince Bernard-Pagan, MD PHD Michael Rooney Alexander Sherry Benjamin Schrank, MD, PhD Badr Id Said, MD Aaron Seo Kathryn Marqueen

The best mentor a resident could ask for. Mahalo, Chad Tang, MD!

Excited to share our recent LancetOncology publication on sequential SBRT for oligometastatic clear cell RCC. Our outcomes show excellent outcomes in 121 patients with 1-5 metastases. MD Anderson Cancer Center Myriad Genetics authors.elsevier.com/a/1ljMf5EIIgTS…

❗️ As VALOR accrues, what is the existing data from STARS ROSEL that SBRT is non-inferior to lobectomy? Using beta moment matching and sampling from this, assuming 5% NI margin, my bet is on SBRT #numpy #matplotlib

Our “Best Of” #ASTRO25 abstract summary is out! 🦾🎯 Featuring plenaries, late-breaking abstracts, and select scientific highlights. I'm sure we missed plenty of gems - what would you add? 👇 bit.ly/BestOfASTRO25

Radiation oncologists are trained to deliver safe, high-precision radiotherapy as part of a #cancer care team. We follow the best available evidence & develop customized, cost-effective plans. Science guides our treatments, but humanity guides our practice. 1/2